Chemomab Therapeutics Ltd - ADR

NEW
STU:2QV (Israel)   ADR
€ 2.98 (0%) Jul 31
At Loss
P/B:
1.04
Market Cap:
€ 21.84M ($ 25.20M)
Enterprise V:
€ 14.85M ($ 17.14M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Chemomab Therapeutics Ltd (STU:2QV) Dividend

Chemomab Therapeutics Ltd (STU:2QV) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -37.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:2QV Dividend

Does Chemomab Therapeutics Ltd (STU:2QV) pay a dividend?

Chemomab Therapeutics Ltd (STU:2QV) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Chemomab Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Chemomab Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -37.6% over the past 3 years.

What are dividend-paying alternatives to Chemomab Therapeutics Ltd?

For dividend-paying alternatives in Chemomab Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.